Clinical Utility of Multigene Profiling Assays in Invasive Early-Stage Breast Cancer
- MeSH Terms
- breast cancer, neoplasm, carcinoma, malignancy, tumor, oncotype, prosigna, PAM50, mammaprint, 70 gene, endopredict, breast cancer index, BCI, tailorx, rxponder, swog, swog S1007, swog S8814, nsabp, nsabp b20, nsabp b-20, nsabp b 20, nsabp b14, nsabp b-14, nsabp b 14, transatac, ma17, ma 17, ma-17, ma12, ma 12, ma-12, ABCSG-6, ABCSG 6, ABCSG-8, ABCSG 8, mindact, raster adj2 study, geicam 9906, geicam-9906, geicam9906, OPTIMA adj2 study, 21 gene, recurrence score
- Guideline Contact
- Duvaraga Sivajohanathan; [email protected]
- Keywords
- breast cancer, oncotype dx, prosigna, mammaprint, endopredict, breast cancer index
- Date for Review
- In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
- Publication Date
- 2022-01-28
- Date of Last Evidence Search
- 2021-12-15
- Methods Applied
- Systematic review-based, Externally reviewed, Evidence quality assessment, Patient/survivors/caregivers participation
- Publication Scope
- Guidelines
- prognosis
- treatment
- Countries of Application
- Canada
- Guideline Publication Status
- Published
- Languages
- English
- Authors
- PEBC (Program in evidenced-based care)
- Publication Year
- 2022